about
Adjuvant Endocrine Therapy in Early Postmenopausal Breast CancerIs withholding osteoporosis medication after fracture sometimes rational? A comparison of the risk for second fracture versus death.Long-term safety and efficacy of raloxifene in the prevention and treatment of postmenopausal osteoporosis: an update.Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early breast cancer: Putting safety issues into perspective.Mining MEDLINE for the treatment of osteoporosis.
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Medical treatment of vertebral osteoporosis
@ast
Medical treatment of vertebral osteoporosis
@en
type
label
Medical treatment of vertebral osteoporosis
@ast
Medical treatment of vertebral osteoporosis
@en
prefLabel
Medical treatment of vertebral osteoporosis
@ast
Medical treatment of vertebral osteoporosis
@en
P2860
P1476
Medical treatment of vertebral osteoporosis
@en
P2093
K Lippuner
P2860
P2888
P304
P356
10.1007/S00586-003-0608-X
P478
12 Suppl 2
P577
2003-09-17T00:00:00Z